Compared to all-cause acute care and the general population, cannabis-related acute care is associated with a higher 5-year dementia risk.

Female primary care physicians (PCPs) in value-based payment models have equal or better quality outcomes and higher earning than their male counterparts.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

Last week, the US Food and Drug Administration announced a move to improve transparency and strengthen the safety of chemicals used in the nation's food supply.

Topical testosterone therapy does not significantly improve functional outcomes beyond supervised exercise training in older women recovering from a hip fracture.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Nonrheumatology physicians in the US demonstrated limited awareness of axSpA and knowledge gaps regarding proper diagnostic lab testing and imaging.

The American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD).

Additional safety signals have been identified with apremilast, with some adverse events specific to certain patient populations.

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.